ATE259221T1 - Magensaftresistente tablette für nahrung, diät und therapie - Google Patents

Magensaftresistente tablette für nahrung, diät und therapie

Info

Publication number
ATE259221T1
ATE259221T1 AT00974794T AT00974794T ATE259221T1 AT E259221 T1 ATE259221 T1 AT E259221T1 AT 00974794 T AT00974794 T AT 00974794T AT 00974794 T AT00974794 T AT 00974794T AT E259221 T1 ATE259221 T1 AT E259221T1
Authority
AT
Austria
Prior art keywords
formulation
diet
therapy
food
juice resistant
Prior art date
Application number
AT00974794T
Other languages
English (en)
Inventor
Alessandro Seneci
Pia Alberico
Original Assignee
Truffini & Regge Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truffini & Regge Farmaceutici filed Critical Truffini & Regge Farmaceutici
Application granted granted Critical
Publication of ATE259221T1 publication Critical patent/ATE259221T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00974794T 1999-10-21 2000-10-20 Magensaftresistente tablette für nahrung, diät und therapie ATE259221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002206A IT1315252B1 (it) 1999-10-21 1999-10-21 Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
PCT/IT2000/000424 WO2001028526A2 (en) 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use

Publications (1)

Publication Number Publication Date
ATE259221T1 true ATE259221T1 (de) 2004-02-15

Family

ID=11383827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974794T ATE259221T1 (de) 1999-10-21 2000-10-20 Magensaftresistente tablette für nahrung, diät und therapie

Country Status (7)

Country Link
EP (1) EP1225876B1 (de)
AT (1) ATE259221T1 (de)
AU (1) AU1300001A (de)
DE (1) DE60008276T2 (de)
ES (1) ES2215079T3 (de)
IT (1) IT1315252B1 (de)
WO (1) WO2001028526A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20300304U1 (de) * 2003-01-09 2003-04-24 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Ocuvite Zink
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
AU2008231570C1 (en) 2007-03-28 2014-11-27 Aker Biomarine Human Ingredients As Bioeffective krill oil compositions
EP2022503B1 (de) 2007-08-07 2011-10-19 Symrise AG Verkapselte Vacciniumextrakte mit ausgewogener Magen-Darm-Freisetzung
US8372812B2 (en) * 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
RS65173B1 (sr) 2014-09-22 2024-03-29 Ntc S R L Kompozicija za prevenciju i/ili lečenje simptoma alergije
ES2937960T5 (en) 2015-02-11 2026-02-16 Aker Biomarine Human Ingredients As Lipid extraction processes
CN107580457A (zh) 2015-02-11 2018-01-12 阿克海洋生物南极股份公司 脂质组合物
ITUB20153066A1 (it) 2015-08-11 2017-02-11 Graal S R L Composizione alimentare e/o nutraceutica contenente pea
CN110191871A (zh) * 2017-01-20 2019-08-30 株式会社钟化 包含谷胱甘肽的粒状肥料
CA3087126A1 (en) 2017-12-27 2019-07-04 Graal S.R.L. Process for the preparation of delayed release solid formulations
CN112618500B (zh) * 2020-12-24 2022-12-09 广州汉光药业股份有限公司 叶酸制剂及其制备方法
JP2022102198A (ja) * 2020-12-25 2022-07-07 ライオン株式会社 内服固形剤
IT202200022413A1 (it) * 2022-10-31 2024-05-01 S I I T S R L Servizio Int Imballaggi Termosaldanti Gommosa multistrato a rilascio differenziato di principi attivi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3914622A1 (de) * 1989-05-03 1990-11-08 Fiegert Seibt Edda Dr Rer Nat Arzneimittel auf basis lipoider grundlagen
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
GB2305604B (en) * 1995-09-29 1999-06-23 Quest Vitamins Ltd Carrier base material
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms

Also Published As

Publication number Publication date
DE60008276D1 (de) 2004-03-18
DE60008276T2 (de) 2004-12-16
ITMI992206A0 (it) 1999-10-21
WO2001028526A3 (en) 2001-12-06
WO2001028526A2 (en) 2001-04-26
IT1315252B1 (it) 2003-02-03
AU1300001A (en) 2001-04-30
EP1225876B1 (de) 2004-02-11
ES2215079T3 (es) 2004-10-01
EP1225876A2 (de) 2002-07-31
ITMI992206A1 (it) 2001-04-21

Similar Documents

Publication Publication Date Title
ATE259221T1 (de) Magensaftresistente tablette für nahrung, diät und therapie
CA2559755C (en) Dietary supplement and method for treating digestive system-related disorders
WO2020009111A1 (ja) 脂肪蓄積抑制用組成物
KR20070111478A (ko) 영양 보충을 위한 조성물과 방법
CN108450938A (zh) 一种减脂代餐粉及其制备方法
US7229646B2 (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease
CA2132427A1 (en) Method and composition for suppresion of side effects of anti-inflammatory drugs
CN107624068B (zh) 包含肉桂醛和锌的组合物及此类组合物的使用方法
JPH08503964A (ja) 食餌療法の低コレステロール血組成物
JP7294147B2 (ja) 侵害受容性疼痛の予防又は改善用組成物
KR20110117685A (ko) 대량 투여 영양 보충물의 부정적인 부작용없이 비타민 및 무기질 결핍을 해결하면서 환경 스트레스의 효과를 제거하고 면역력을 개선시키고 에너지를 개선시키는 멀티비타민/무기질 제형
JP2006160697A (ja) 睡眠健康改善剤
Miller Unresolved Feeding and Nutrition Problems of the Chronically III Aged
Spies Some recent advances in nutrition
Kenny et al. Clinical zinc deficiency during adequate enteral nutrition.
JPH06192104A (ja) 幼児における新陳代謝異常の治療および予防のための組成物
Morell et al. The nourishing traditions book of baby & child care
CN113840538B (zh) 膳食丁酸酯
Opper et al. Esophageal obstruction with a dietary fiber product designed for weight reduction
Karvonen et al. Safety and possible antidiarrhoeal effect of the probiotic Lactobacillus reuteri after oral administration to neonates
Hegedus et al. Dietetics in a cancer hospital
JP2004041006A (ja) 液状栄養組成物
Blandford et al. Muscle contractures associated with glucocorticoid deficiency
SPIES et al. Detection and treatment of severe atypical deficiency disease
Vagnini et al. The side effects bible: the dietary solution to unwanted side effects of common medications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties